Judge Saylor denied GSK’s first Motion to Dismiss all of the pending Zofran cases on preemption grounds last year. Read more
The whistleblower suit was filed in New Jersey, contending the employee was fired for speaking out about unreliable study results that have underpinned the deceptive marketing of a smoking c... Read more
The Third Circuit further noted, “The conduct that allegedly caused plaintiffs’ injuries is the same conduct forming the basis of the RICO scheme alleged in the complaint – the misrepresenta... Read more
Drugmaker GlaxoSmithKline closed its North Carolina factory on August 11 after testing at a cooling tower found bacteria that causes deadly Legionnaire’s disease, a company spokeswoman said.... Read more
GlaxoSmithKline PLC (GSK) has agreed in another settlement to pay $105 million to 44 states and the District of Columbia. This settlement resolves allegations that the company improperly mar... Read more
Drug giant GlaxoSmithKline has agreed to pay the state of West Virginia $22 million to settle a lawsuit that alleged the company illegally promoted its Avandia diabetes medicine. The British... Read more
A New Jersey federal jury has returned a $106.7 million verdict against GlaxoSmithKline LLC (GSK) in a suit brought by Mylan Inc. The jury found that GSK breached an exclusive contract by al... Read more
In a groundbreaking ruling, an Illinois federal judge determined that GlaxoSmithKline PLC (GSK) can be held liable for a corporate and securities lawyer’s suicide. The lawyer had taken a gen... Read more
Following concerns that it hid important clinical data on Avandia, drug maker GlaxoSmithKline (GSK) has now agreed to share more clinical data. GSK was recently fined for withholding safety... Read more
Teva Pharmaceuticals has pulled its generic version of a popular antidepressant off the market after a federal analysis showed the pill does not work properly. The Food and Drug Administrati... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.